Global Cancer Drug Spending Hit the $100 Billion Mark in 2014

Global Cancer Drug Spending Hit The $100 Billion Mark In 2014 ...

Bidness ETC-3 hours ago

Earlier this year, the largest pharmacy-benefit manager in the US, managed to draw out steep discounts on hepatitis C drugs from Gilead Sciences, Inc.

IMS Health Report Shows Global Spending For Cancer Drugs Now ...
Tech Times-4 hours ago

Explore in depth  (48 more articles)